Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

NCT06766500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Empagliflozin + Metformin hydrochloride 5 mg/850 mg combination film-coated tablets
DRUG: Synjardy® 5 mg/850 mg film-coated tablets

Sponsor

Gedeon Richter Plc.